Back
75· Active
Health & Science1h 44m ago
An independent expert panel voted 10-1 against the effectiveness and 9-2 against the safety profile of MDMA-assisted therapy for PTSD based on current trial data.
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA) Advisory Committee
What
An independent expert panel voted 10-1 against the effectiveness and 9-2 against the safety profile of MDMA-assisted therapy for PTSD based on current trial data.
When
Wed, 10 Jun 2026 12:10:06 GMT · 1h 44m ago
Where
Silver Spring, Maryland, USA · 39.0349°N, 76.9934°W
Why
The committee cited concerns over functional unblinding in clinical trials and potential cardiovascular risks, suggesting the submitted data did not sufficiently prove benefits outweighed the risks.
The Frontline Impact
How this affects you
This recommendation serves as a major setback for psychedelic medicine; global biotech investors and patients may see delays in the commercial availability of similar breakthrough therapies.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.